Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44

Dina Bashir Kamil Abu Samra, Fajr A Aleisa, Asma S. Al-Amoodi, Heba M. Jalal Ahmed, Chee Jia Chin, Ayman AbuElela, Ptissam Bergam, Rachid Sougrat, Jasmeen Merzaban

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

CD34 is routinely used to identify and isolate human hematopoietic stem/progenitor cells (HSPCs) for use clinically in bone marrow transplantation, but its function on these cells remains elusive. Glycoprotein ligands on HSPCs help guide their migration to specialized microvascular beds in the bone marrow that express vascular selectins (E- and P-selectin). Here, we show that HSPC-enriched fractions from human hematopoietic tissue expressing CD34 (CD34pos) bound selectins, whereas those lacking CD34 (CD34neg) did not. An unbiased proteomics screen identified potential glycoprotein ligands on CD34pos cells revealing CD34 itself as a major vascular selectin ligand. Biochemical and CD34 knockdown analyses highlight a key role for CD34 in the first prerequisite step of cell migration, suggesting that it is not just a marker on these cells. Our results also entice future potential strategies to investigate the glycoforms of CD34 that discriminate normal HSPCs from leukemic cells and to manipulate CD34neg HSPC-enriched bone marrow or cord blood populations as a source of stem cells for clinical use.
Original languageEnglish (US)
Pages (from-to)2799-2816
Number of pages18
JournalBlood advances
Volume1
Issue number27
DOIs
StatePublished - Dec 26 2017

Fingerprint Dive into the research topics of 'Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44'. Together they form a unique fingerprint.

Cite this